IS5572A - Orkuríkar sýklódextrínfléttur - Google Patents
Orkuríkar sýklódextrínflétturInfo
- Publication number
- IS5572A IS5572A IS5572A IS5572A IS5572A IS 5572 A IS5572 A IS 5572A IS 5572 A IS5572 A IS 5572A IS 5572 A IS5572 A IS 5572A IS 5572 A IS5572 A IS 5572A
- Authority
- IS
- Iceland
- Prior art keywords
- rich
- energy
- cyclodextrin complexes
- cyclodextrin
- complexes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
- C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7554498P | 1998-02-23 | 1998-02-23 | |
PCT/IS1999/000003 WO1999042111A1 (fr) | 1998-02-23 | 1999-02-16 | Complexes de cyclodextrine extremement energetiques |
Publications (1)
Publication Number | Publication Date |
---|---|
IS5572A true IS5572A (is) | 2000-08-16 |
Family
ID=22126450
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS5572A IS5572A (is) | 1998-02-23 | 2000-07-25 | Orkuríkar sýklódextrínfléttur |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1067942A1 (fr) |
JP (1) | JP2003522207A (fr) |
AU (1) | AU759280C (fr) |
CA (1) | CA2320772A1 (fr) |
IS (1) | IS5572A (fr) |
NZ (1) | NZ505951A (fr) |
WO (1) | WO1999042111A1 (fr) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU7937500A (en) * | 1999-10-27 | 2001-05-08 | Farmarc Nederland Bv | Pharmaceutical composition containing midazolam |
EP1267941B1 (fr) * | 2000-03-28 | 2005-11-23 | Farmarc Nederland B.V. | Complexes d'inclusion d'alprazolame et compositions pharmaceutiques les contenant |
NZ530227A (en) | 2001-06-18 | 2006-09-29 | Noven Pharma | Enhanced drug delivery in transdermal systems |
WO2003022270A1 (fr) * | 2001-09-13 | 2003-03-20 | Noven Pharmaceuticals, Inc. | Administration transcutanee d'un ester d'enalapril |
US6805878B2 (en) | 2001-09-13 | 2004-10-19 | Noven Pharmaceuticals, Inc. | Transdermal administration of ACE inhibitors |
SI1515729T1 (sl) * | 2002-06-13 | 2008-08-31 | Novartis Ag | Kvaternizirane amonij ciklodekstrinske spojine |
RS20050735A (en) | 2003-03-28 | 2008-06-05 | Ares Trading S.A., | Cladribine formulations for improved oral and transmucosal delivery |
US20070020299A1 (en) | 2003-12-31 | 2007-01-25 | Pipkin James D | Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
RU2390330C2 (ru) | 2003-12-31 | 2010-05-27 | Сайдекс, Инк. | Ингаляционная препаративная форма, содержащая простой сульфоалкиловый эфир гамма-циклодекстрина и кортикостероид |
GB0400804D0 (en) * | 2004-01-14 | 2004-02-18 | Innoscience Technology Bv | Pharmaceutical compositions |
MXPA06012240A (es) | 2004-04-23 | 2007-01-31 | Cydex Inc | Formulacion para inhalador de polvo seco que contiene eter sulfoalquilico-ciclodextrina. |
MX348982B (es) | 2005-10-26 | 2017-07-06 | Cydex Pharmaceuticals Inc | Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas. |
US7629331B2 (en) | 2005-10-26 | 2009-12-08 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof |
US8455471B2 (en) * | 2006-10-20 | 2013-06-04 | Icos Corporation | Compositions of CHK1 inhibitors and cyclodextrin |
JP2010510311A (ja) * | 2006-11-21 | 2010-04-02 | ノバルティス アーゲー | ベンゾジアゼピン構造のrsv阻害剤を含む安定な非経腸製剤 |
EP3766493B1 (fr) | 2007-04-27 | 2023-08-23 | CyDex Pharmaceuticals, Inc. | Méthode de stabilisation du clopidogrel en utilisant de la sulfoalkyl-éther cyclodextrine |
EP2106786A1 (fr) | 2008-04-04 | 2009-10-07 | Roewer, Norbert, Univ.-Prof. Dr. med. | Préparation pharmaceutique comprenant du cyclodextrine permethylé |
US7635773B2 (en) | 2008-04-28 | 2009-12-22 | Cydex Pharmaceuticals, Inc. | Sulfoalkyl ether cyclodextrin compositions |
US10463677B2 (en) | 2008-11-07 | 2019-11-05 | Cydex Pharmaceuticals, Inc. | Composition containing sulfoalkyl ether cyclodextrin and latanoprost |
AU2009335206B2 (en) | 2008-12-29 | 2013-03-14 | Unilever Plc | Food products enriched with methylxanthines |
JP5808739B2 (ja) | 2009-05-13 | 2015-11-10 | サイデックス・ファーマシューティカルズ・インコーポレイテッド | プラスグレル及びシクロデキストリン誘導体を含む医薬組成物並びにその製造方法及び使用方法 |
AU2011254726B2 (en) | 2010-05-19 | 2014-03-06 | Upfield Europe B.V. | Theobromine for increasing HDL-cholesterol |
EP2678320B1 (fr) | 2011-02-23 | 2018-09-19 | Coeruleus Ltd. | Complexes de flumazénil, compositions les comprenant et leurs utilisations |
DK2814849T3 (da) | 2012-02-15 | 2020-03-09 | Cydex Pharmaceuticals Inc | Fremgangsmåde til fremstilling af cyclodextrin-derivater |
CA2865950C (fr) | 2012-02-28 | 2016-12-20 | Cydex Pharmaceuticals, Inc. | Compositions de cyclodextrine alkylee et procedes pour leur preparation et leur utilisation |
NZ707323A (en) | 2012-10-22 | 2018-11-30 | Cydex Pharmaceuticals Inc | Alkylated cyclodextrin compositions and processes for preparing and using the same |
KR102147084B1 (ko) | 2012-11-15 | 2020-08-24 | 자피오텍 게엠베하 | 소염성 활성 물질 또는 면역 억제성 활성물질로서 델피니딘 복합제 |
EP2931287B1 (fr) | 2012-12-11 | 2017-10-04 | Sapiotec GmbH | Delphinidin contre les cellules de mélanome |
WO2016029179A1 (fr) | 2014-08-22 | 2016-02-25 | Cydex Pharmaceuticals, Inc. | Compositions de cyclodextrine alkylée fractionnées et leurs procédés de préparation et d'utilisation |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5376645A (en) * | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
US5324718A (en) * | 1992-07-14 | 1994-06-28 | Thorsteinn Loftsson | Cyclodextrin/drug complexation |
US5472954A (en) * | 1992-07-14 | 1995-12-05 | Cyclops H.F. | Cyclodextrin complexation |
-
1999
- 1999-02-16 NZ NZ505951A patent/NZ505951A/xx unknown
- 1999-02-16 EP EP99906440A patent/EP1067942A1/fr not_active Withdrawn
- 1999-02-16 AU AU26385/99A patent/AU759280C/en not_active Ceased
- 1999-02-16 JP JP2000532126A patent/JP2003522207A/ja not_active Withdrawn
- 1999-02-16 WO PCT/IS1999/000003 patent/WO1999042111A1/fr not_active Application Discontinuation
- 1999-02-16 CA CA002320772A patent/CA2320772A1/fr not_active Abandoned
-
2000
- 2000-07-25 IS IS5572A patent/IS5572A/is unknown
Also Published As
Publication number | Publication date |
---|---|
AU2638599A (en) | 1999-09-06 |
JP2003522207A (ja) | 2003-07-22 |
CA2320772A1 (fr) | 1999-08-26 |
AU759280C (en) | 2004-01-22 |
AU759280B2 (en) | 2003-04-10 |
WO1999042111A1 (fr) | 1999-08-26 |
EP1067942A1 (fr) | 2001-01-17 |
NZ505951A (en) | 2003-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS5572A (is) | Orkuríkar sýklódextrínfléttur | |
DK1075281T3 (da) | Polyol-IFN-beta-konjugater | |
DE69932980D1 (de) | Resolversignalverarbeitungssystem | |
NO20010193L (no) | Tiobenzimidazol-derivater | |
ATE236136T1 (de) | Benzosulfonderivate | |
NO994875D0 (no) | Forbundne metallkomplekser | |
ATE259810T1 (de) | Phenyl-xanthinderivate | |
NO20010514L (no) | Aminometylkarboksylsyre-derivater | |
DE59907315D1 (de) | Fahrzeugrechneranordnung | |
ATE234316T1 (de) | Metallocenkomplexe | |
DE69902762D1 (de) | Riser-spannanordnung | |
DE69925655D1 (de) | Rückleuchte | |
DK1115716T3 (da) | 2-phenylpyran-4-on-derivater | |
ATE233253T1 (de) | Chromanderivate | |
DK1134219T3 (da) | Cucloalkylsubstituerede aminomethylpyrrolidinderivater | |
DK1060183T3 (da) | 5-deoxycytidinderivater | |
FI980759A0 (fi) | Taetningskonstruktion foer suglaodan i en sugvals | |
DE59907635D1 (de) | Pyrazolyldioxothiochromanoyl-derivate | |
SE9901098L (sv) | Fördelarlåda | |
FI980743A0 (fi) | Gap-valsformare i en pappersmaskin | |
DE59807199D1 (de) | Zerspaner | |
FIU980508U0 (fi) | Puukuitulevy | |
UA2866S (uk) | Втулка | |
FI4121U1 (fi) | Poikittaiskuljetin | |
DK199800333U3 (da) | Kombinationsprodukt |